It has been just a decade since Dr. Stacey Finley, a Diverse 2015 Emerging Scholar, graduated summa cum laude from Florida A&M University (FAMU) with a bachelor’s in chemical engineering. She has packed so much scholarship, research, teaching and service into those intervening years that, today, at age 32, she might easily be considered a prodigy. The tenure-track assistant professor earned a Ph.D. in chemical engineering five years ago at Northwestern University and proceeded to a postdoctoral fellowship at Johns Hopkins University School of Medicine, focusing her research on developing predictive mathematical models to study tumor angiogenesis, cancer metabolism and cancer immunotherapy.
No one had to push Finley toward STEM disciplines in Kansas when she was in high school, or elementary school for that matter. She was drawn to science and math at an early age and urged by her parents—her teacher mother and pastor father—to bring home top grades in all of her classes and to pursue whatever field she chose.
“My parents encouraged me to go after the things I was interested in, but I didn’t have any direct role models [in the field] before college, so when I got to FAMU it was a really great environment for me because I could see faculty who looked like me. It was a great environment for me to grow and develop in engineering,” she says, noting that her high school in Kansas only had about 30 percent people of color, so FAMU, an HBCU, “was a great environment for me.”
“I applied to lots of undergraduate institutions,” she recalls, “but someone from FAMU came up [to Kansas] and talked with me, and I went down for a visit and really fell in love with [the] campus and the atmosphere.”
With a full academic scholarship, after completing her core courses in the first two years, she enrolled in the joint Florida A&M University-Florida State University School of Engineering where she studied chemical engineering.
“My work is in the area of cancer—there are lots of different driving factors that influence the growth and development of cancers, and two of those are the areas I am studying in my own research,” Finley explains.
“One is called angiogenesis, [which] is the growth of new blood vessels, the blood vessels are the way in which the tumor gets the oxygen and nutrients it needs to grow and survive … and what we’re looking at doing in my research is to understand the signaling pathways that lead to the growth of these new blood vessels in the tumors and how we can stop those blood vessels from growing.”
